WebCorresponding Author: Brian A. Ference, MD, MPhil, MSc, Centre for Naturally Randomized Trials, University of Cambridge, 2 Worts’ Causeway, Cambridge CB1 8RN, United Kingdom ([email protected]). Conflict of Interest Disclosures: Dr Ference reported receiving grants and personal fees from Amgen and Merck; grants from … WebJan 29, 2024 · Brian A Ference 1 2 3 , John J P Kastelein 4 , Kausik K Ray 5 , Henry N Ginsberg 6 , M John Chapman 7 , Chris J Packard 8 , Ulrich Laufs 9 , Clare Oliver-Williams 3 , Angela M Wood 3 , Adam S Butterworth 3 , Emanuele Di Angelantonio 3 , John Danesh 3 , Stephen J Nicholls 10 , Deepak L Bhatt 11 , Marc S Sabatine 11 , Alberico L …
Brian Ference Radcliffe Cardiology
WebJun 28, 2024 · Brian A. Ference ([email protected])Search for more papers by this author. Brian A. Ference, Corresponding Author. Brian A. Ference [email protected] Centre for Naturally Randomized Trials, Strangeways Research Laboratory, University of Cambridge, Cambridge, UK. WebAug 31, 2024 · Brian Ference, MD, MPhil, MSc, talks about a new lifetime risk equation he and his team developed that can more accurately predict cardiovascular risk and tr... palinsesto si
Mendelian randomization studies: using naturally randomized ... - LWW
WebVikas Veeranna, Sandip Zalawadiya, Ashutosh Niraj, Abhimanyu Kumar, Brian A. Ference, Luis Afonso The HARD2C Score for Predicting Asymptomatic Peripheral Arterial Disease WebDec 1, 2016 · Ference BA, Yoo W, Alesh I, et al. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian ... WebAug 14, 2024 · Ference, Brian A ; Cannon, Christopher P ; Landmesser, Ulf et al. / Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins : an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration. In: European Heart … palinsesto sisal calcio